Skip to main content

Published locations for Enasidenib gets FDA approval for AML with IDH2 mutations

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Enasidenib gets FDA approval for AML with IDH2 mutations

User login

  • Reset your password
  • /content/enasidenib-gets-fda-approval-aml-idh2-mutations
  • /hematologynews/article/143735/aml/enasidenib-gets-fda-approval-aml-idh2-mutations
  • /oncologypractice/article/143735/aml/enasidenib-gets-fda-approval-aml-idh2-mutations
  • /hematology-oncology/article/143735/aml/enasidenib-gets-fda-approval-aml-idh2-mutations